Company / Operating Cash Flow per Share
Vanda Pharmaceuticals Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$0.22
FY2025
5-year range
$0.22 / $1.13
FY2021-FY2025
Trend
-60.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-1.90 in FY2016 to $1.13 in FY2023.
Based on SEC 10-K filings.
0.22 in FY2025 with a 5-year CAGR of -17.1%.
Declined from $1.13 to $0.22 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -38.1%
- 5-Year CAGR
- -17.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 60.5% year-over-year.
- Peak operating cash flow per share was recorded in FY2023.
- Lowest operating cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.22 | -60.5% |
| FY2024 | $0.56 | -50.8% |
| FY2023 | $1.13 | +22.1% |
| FY2022 | $0.93 | +10.6% |
| FY2021 | $0.84 | +49.6% |
| FY2020 | $0.56 | +1581.9% |
| FY2019 | -$0.04 | +79.0% |
| FY2018 | -$0.18 | -163.7% |
| FY2017 | $0.28 | +114.9% |
| FY2016 | -$1.90 | -99.6% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026